Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The dramatic global rise of MDR and XDR Enterobacterales in human medicine forced clinicians to the reintroduction of colistin as last-resort drug. Meanwhile, colistin is used in the veterinary medicine since its discovery, leading to a steadily increasing prevalence of resistant isolates in the livestock and meat-based food sector. Consequently, transmission of resistant isolates from animals to humans, acquisition via food and exposure to colistin in the clinic are reasons for the increased prevalence of colistin-resistant Enterobacterales in humans in the last decades. Initially, resistance mechanisms were caused by mutations in chromosomal genes. However, since the discovery in 2015, the focus has shifted exclusively to mobile colistin resistances (mcr). This review will advance the understanding of chromosomal-mediated resistance mechanisms in Enterobacterales. We provide an overview about genes involved in colistin resistance and the current global situation of colistin-resistant Enterobacterales. A comparison of the global colistin use in veterinary and human medicine highlights the effort to reduce colistin sales in veterinary medicine under the One Health approach. In contrast, it uncovers the alarming rise in colistin consumption in human medicine due to the emergence of MDR Enterobacterales, which might be an important driver for the increasing emergence of chromosome-mediated colistin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241 · cited 3×
“…family of Enterobacterales is a large group of Gram-negative bacteria and members, such as Escherichia, Klebsiella, Salmonella, Enterobacter, Serratia, Citrobacter and Proteus, are common inhabitants of the gastrointestinal tract of humans and animals (Guentzel, 1996; Marshall and Levy, 2011).”
BackgroundJajere, S. M. (2019) · Veterinary World · doi:10.14202/vetworld.2019.504-521 · Cited by 621
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses
Van, T. T. H., Yidana, Z., Smooker, P. M., & Coloe, P. J. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.07.031 · Cited by 451
Levy, S. B., FitzGerald, G. B., & Macone, A. B. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951103 · Cited by 352
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118423 · Cited by 275 · cited 1×
“LpxM (MsbB) is responsible for the acylation of Lipid A in Enterobacterales (Somerville et al. 1996; Khan et al. 1998).”
Background
Cited by
Horizontal Gene Transfer of Antibiotic Resistance Genes in Biofilms
Michaelis, C., & Grohmann, E. (2023) · Antibiotics · doi:10.3390/antibiotics12020328 · Cited by 612
Ohene Larbi, R., Adeapena, W., Ayim-Akonor, M., Ansa, E. D. O., Tweya, H., Terry, R. F., Labi, A.-K., & Harries, A. D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610449 · Cited by 14
“6%, although incidence rates have risen over the last five years in all continents, largely as a result of inappropriate use of the antimicrobial in animal husbandry [41].”
Background
Metadata
- Authors
- Binsker, U., Käsbohrer, A., & Hammerl, J. A.
- Venue
- FEMS Microbiology Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-06
- Volume
- 46
- Issue
- 1
- ISSN
- 0168-6445 (ISSN-L)
- 1574-6976
- OpenAlex
- W4229075273
- Cited by
- 170
- References
- 6
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.